Heartflow, Inc. Common Stock (HTFL) has 8 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Bain Capital Life Sciences Investors, LLC mit 10,448,158 Aktien. Weitere bedeutende Anteilseigner sind Farquhar John C.M. und Lightcap Jeffrey C.
In den letzten 12 Monaten haben Insider 23 Transaktionen in HTFL Aktien getätigt — 5 Käufe (im Wert von $13.33M) und 7 Verkäufe (im Wert von $59.36M). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
HTFL Insider-Beteiligungen
Größter Aktionär
Bain Capital Life Sciences Investors, LLC
10,448,158 Aktien
Käufe (12 Monate)
5
$13.33M Wert
Verkäufe (12 Monate)
7
$59.36M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
10,448,158 |
2026-02-06 |
|
| 2 |
Farquhar John C.m. |
Chief Executive Officer |
571,725 |
2026-03-20 |
|
| 3 |
Lightcap Jeffrey C |
Director |
246,261 |
2026-03-26 |
|
| 4 |
Verghese Vikram |
Chief Financial Officer |
119,685 |
2026-02-10 |
|
| 5 |
Rogers Campbell |
Chief Medical Officer |
78,518 |
2026-03-23 |
|
| 6 |
Cullivan Julie A |
Director |
27,291 |
2026-03-06 |
|
| 7 |
Barabe Timothy C |
Director |
15,412 |
2026-03-12 |
|
| 8 |
Jones Marie L. |
Chief Accounting Officer, VP |
10,021 |
2026-02-10 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-01 |
Rogers Campbell |
Chief Medical Officer |
Optionsausübung (Verkauf) |
6,849 |
$2.22 |
$15.2K |
| 2026-03-24 |
Lightcap Jeffrey C |
Director |
Sonstige (Kauf) |
206,261 |
- |
- |
| 2026-03-24 |
Healthcor Partners Management Lp |
Director |
Sonstige (Verkauf) |
4,615,542 |
- |
- |
| 2026-03-19 |
Rogers Campbell |
Chief Medical Officer |
Informierter Verkauf |
64,533 |
$25.69 |
$1.66M |
| 2026-03-18 |
Farquhar John C.m. |
Chief Executive Officer |
Informierter Verkauf |
9,725 |
$25.00 |
$243.13K |
| 2026-03-10 |
Farquhar John C.m. |
Chief Executive Officer |
Informierter Verkauf |
12,837 |
$22.66 |
$290.89K |
| 2026-03-06 |
Farquhar John C.m. |
Chief Executive Officer |
RSU-Zuteilung |
2,631 |
$16.15 |
$42.49K |
| 2026-03-11 |
Barabe Timothy C |
Director |
Optionsausübung (Verkauf) |
8,667 |
$2.22 |
$19.24K |
| 2026-03-05 |
Cullivan Julie A |
Director |
Informierter Verkauf |
9,122 |
$25.00 |
$228.05K |
| 2026-02-17 |
Barabe Timothy C |
Director |
Optionsausübung (Verkauf) |
2,497 |
$8.33 |
$20.8K |
| 2026-02-12 |
Rogers Campbell |
Chief Medical Officer |
Optionsausübung (Verkauf) |
39,709 |
$8.33 |
$330.78K |
| 2026-02-06 |
Verghese Vikram |
Chief Financial Officer |
RSU-Zuteilung |
119,685 |
$27.74 |
$3.32M |
| 2026-02-06 |
Jones Marie L. |
Chief Accounting Officer, VP |
RSU-Steuereinbehalt |
94 |
$27.74 |
$2.61K |
| 2026-02-10 |
Farquhar John C.m. |
Chief Executive Officer |
Informierter Verkauf |
22,562 |
$27.46 |
$619.55K |
| 2026-02-06 |
Farquhar John C.m. |
Chief Executive Officer |
RSU-Zuteilung |
321,259 |
$27.74 |
$8.91M |
| 2026-02-06 |
Rogers Campbell |
Chief Medical Officer |
RSU-Steuereinbehalt |
515 |
$27.74 |
$14.29K |
| 2026-02-05 |
Cullivan Julie A |
Director |
Informierter Verkauf |
8,000 |
$27.32 |
$218.56K |
| 2026-02-04 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Informierter Verkauf |
2,000,000 |
$28.05 |
$56.1M |
| 2025-12-16 |
Lightcap Jeffrey C |
Director |
Informierter Kauf |
40,000 |
$26.34 |
$1.05M |
| 2025-11-07 |
Verghese Vikram |
Chief Financial Officer |
RSU-Steuereinbehalt |
471 |
$32.56 |
$15.34K |
| 2025-11-07 |
Jones Marie L. |
Chief Accounting Officer, VP |
RSU-Steuereinbehalt |
81 |
$32.56 |
$2.64K |
| 2025-11-07 |
Farquhar John C.m. |
Chief Executive Officer |
RSU-Steuereinbehalt |
1,339 |
$32.56 |
$43.6K |
| 2025-11-07 |
Rogers Campbell |
Chief Medical Officer |
RSU-Steuereinbehalt |
439 |
$32.56 |
$14.29K |
